investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Immunophysiological Mechanisms in the Biological Therapy of Cancer

Robert Wiltrout

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
The goal is to evaluate the anti-tumor and immunomodulatory potential of AstraZeneca's proprietary compounds, AZD8055 (mTOR blocker) and AZD2171 (VEGF blocker).

Related projects